TIDMSN.

RNS Number : 6133S

Smith & Nephew Plc

17 March 2021

SMITH & NEPHEW PLC

17 March 2021

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Following the announcement on 9 March 2021, regarding the awards made under the Smith & Nephew Global Share Plan 2020 of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company"), those share awards vested on 16 March 2021.

1. FINAL VESTING ON 16 MARCH 2021 OF SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE 2018 PERFORMANCE SHARE PROGRAMME AWARDS:

The awards were granted under the Global Share Plan 2020 on 8 March 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

The following relates to all individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            ------------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------------- 
 Nature of the transaction   Final vesting on 16 March 2021 of Supplementary 
                              Awards granted under the Smith & Nephew 
                              Global Share Plan 2020 for the 2018 Performance 
                              Share Programme awards . 
                            ------------------------------------------------- 
 Date of Transaction         2021 - 03 - 16 
                            ------------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------------- 
 
 
                                                                                                Total Ordinary 
                                                                                                 Share Holding 
                                                                           Total Ordinary        as a % of 
                                                                            Share Holding        the Company's 
                                                                            following            ISC following 
 Name                            Price                      Aggregated      the transaction      the transaction 
  (Position)           Status     (GBP)    Volume            information    *                    * 
                                           3,740 
                                            (of which                      84,165.76313 
 Bradley Cannon                             1,665                           ordinary 
  (President                                were sold                       shares (including 
  Sports Medicine                           and 2,075       N/A Single      2,101.64550 
  & ENT)               PDMR      14.0000    retained)        Transaction    in ADS')            0.00951% 
                      --------  --------  ---------------  -------------  -------------------  ----------------- 
 Phil Cowdy                                1,781 
  (Chief Business                           (of which 
  Development                               841 were                       45,298.19975 
  & Corporate                               sold and        N/A Single      ordinary 
  Affairs Officer)     PDMR      14.0000    940 retained)    Transaction    shares              0.00512% 
                      --------  --------  ---------------  -------------  -------------------  ----------------- 
                                           2,848 
                                            (of which                      106,816.00000 
                                            1,125                           ordinary 
 Elga Lohler                                were sold                       shares (including 
  (Chief HR                                 and 1,723       N/A Single      3,015.00000 
  Officer)             PDMR      14.0000    retained)        Transaction    in ADS')            0.01207% 
                      --------  --------  ---------------  -------------  -------------------  ----------------- 
                                           2,823 
 Catheryn                                   (of which                      81,517.23565 
  O'Rourke                                  963 were                        ordinary 
  (Chief Legal                              sold and                        shares (including 
  & Compliance                              1,860           N/A Single      5,818.25734 
  Officer)             PDMR      14.0000    retained)        Transaction    in ADS')            0.00921% 
                      --------  --------  ---------------  -------------  -------------------  ----------------- 
                                           3,207 
                                            (of which 
 Vasant Padmanabhan                         1,089 
  (President                                were sold                      64,620.00000 
  Research                                  and 2,118       N/A Single      ordinary 
  & Development)       PDMR      14.0000    retained)        Transaction    shares              0.00730% 
                      --------  --------  ---------------  -------------  -------------------  ----------------- 
                                           1,255 
                                            (of which 
 Susan Swabey                               592 were                       49,225.83952 
  (Company                                  sold and        N/A Single      ordinary 
  Secretary)           PDMR      14.0000    663 retained)    Transaction    shares              0.00556% 
                      --------  --------  ---------------  -------------  -------------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFLEVTIDLIL

(END) Dow Jones Newswires

March 17, 2021 11:30 ET (15:30 GMT)